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Background: Lichen planus (LP) is a chronic autoimmune disease that affects the oral mucosa as well as the skin, 
genital mucosa and other sites. 
Objective: To evaluate the correlation between oral, genital and cutaneous lichen planus, in a sample of LP pa-
tients. 
Material and Methods: This descriptive study reviewed 274 clinical histories of patients, who all presented histo-
logical confirmation of lichen planus verified by a pathologist, attending research centers in Barcelona. 
Results: A total of 40 LP patients (14.59%) presented genital lesions. Of 131 patients with cutaneous LP (47.8%), 
the most commonly affected zones were the body’s flexor surfaces, representing 60.1% of cases. 24% of patients 
(n=55) related the start of the lesions with previous stress events. Of the 131 subjects with cutaneous lesions, 19% 
(n=25) also presented oral lichen planus (OLP). Of the total sample, 53.6% (n=147) of patients presented oral le-
sions. The systemic diseases most commonly associated with this patient sample were psychological problems 
such as stress, anxiety and depression (48%), hypertension (27%), gastric problems (12%), and diabetes (9.7%). A 
family history of lichen planus was found in only 2 cases (0,72%) out of the total of 274. 
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Introduction
Lichen Planus (LP) is a chronic inflammatory mucocu-
taneous disease that affects the skin, mucosa, or both. It 
is recurrent, of unknown etiology, and can adopt differ-
ent clinical appearances depending on its time of evo-
lution, localization, and severity. LP generally evolves 
with unpredictable spells of remission and intensifica-
tion (1-3). The most common dermatological disease to 
present oral manifestations, it affects the oral mucosa 
with an estimated prevalence of 0.5-3%, and a female/
male ratio ranging between 1.5 and 3. The age of onset 
is generally between 30 and 60 years and the disease 
also has a much-debated premalignant potential (1,4). 
Exclusively oral presentation occurs in one in three pa-
tients, the oral mucosa, tongue and gums being the most 
common sites (5,6). Oral lichen planus (OLP) manifes-
tations usually continue for years, alternating between 
periods of latency and exacerbation (7). Biopsies will 
confirm a clinically presumed diagnoses, and will also 
exclude areas showing signs of cell atypia and malig-
nancy – manifestations that are incompatible with li-
chen diagnosis (4,8,9).
Histologically, the disease appears as: i) an inflamma-
tory infiltrate in the papillary corium, which takes on a 
characteristic band-like distribution; ii) hyperkeratosis 
with ortho and/or parakeratosis; iii) vacuolating degen-
eration of the basal layer of the epithelium (10,11). 
LP’s possible malign transformation is a highly con-
troversial topic (9,12). Although risk is low, monitoring 
patients with the disease has provided evidence of its 
potential malignancy (13-15). Modifying some of the 
criteria outlined above, Warnakulasuriya et al. (16) 
included OLP as a potentially malignant disorder and 
most researchers recommend indefinite monitoring of 
OLP patients, aiming at early detection of the potential 
malignization.
Studies of OLP patients usually ignore extra-oral (cu-
taneous and/or genital) manifestations (17). Earlier re-
search such as Eisen (1999) (18) states that genital in-
volvement is seen in approximately 25% of men with 
skin involvement, whereas the frequency in women is 
unknown (17-19). Vulvovaginal LP can appear in isola-
tion or in association with other manifestations at other 
sites. It is estimated that approximately 50% of women 
with OLP also present vulva affectation (17,20,21) but it 
also believed that this might be infra-diagnosed (22) and 
that in fact the incidence of affectation is higher (23-25). 
Meanwhile, two thirds of patients with vulva affecta-
tion also suffer vaginal and gingival affectation; this is 
known as vulvo-vaginal-gingival syndrome (17,26,27).
The oral form of lichen planus occurs more frequently 
and tends to be more resistant to treatment than the cu-
taneous form. In surveys of patients with oral lichen pla-
nus, the subject of extra oral manifestations has rarely 
been broached or if so, has focused almost exclusively 
on cutaneous involvement. Among the few studies that 
document skin lesions in patients with oral lichen pla-
nus, the reported incidence is very inconsistent, varying 
from 4 to 44%. Other authors affirm that approximately 
one third of patients presenting oral lesions also pres-
ent skin lesions (3,18,28). Importantly, in addition to the 
skin, other affected extra-oral areas include the genital 
and anal mucous membranes, the scalp, and the nails 
(28,29). 
As mentioned above, few studies have investigated the 
simultaneous presentation of LP in the mouth and other 
areas of the body.  Most research has studied either oral 
lesions or extraoral lesions in isolation. Also, descrip-
tive studies assessing a high number of Spanish popula-
tion with lichen planus oral, cutaneous and genital is 
limited. In response to this scenario, the present de-
scriptive study evaluated the correlation between oral, 
genital and cutaneous LP, in a sample of LP patients. 
Material and Methods
This descriptive study reviewed the clinical histories of 
274 patients who all presented histological confirmation 
of lichen planus verified by a pathologist. The patient 
sample was selected from patients attending either the 
University of Barcelona Dental Hospital, Faculty of 
Dentistry (Bellvitge University Campus) (subgroup A) 
or the Sacrat Cor Hospital, Barcelona (subgroup B).  
All patients who met the assessment criteria were in-
cluded in the study. Diagnosis was determined by clini-
cal examination and confirmed by histopathological 
findings characteristic of lichen planus. In this study 
we did not distinguish between patients with oral lichen 
planus and oral lichenoid lesion.
A clinical history protocol was completed for each pa-
tient registering the following variables: age and sex, 
clinical history, medication use, smoking and alcohol 
consumption, family history of LP, duration of lesions 
(in the mouth, wrists, feet/ankles, back, upper extremi-
ties, genitals, axillae, abdomen, nails, scalp, face, or 
Conclusions: Any patient with OLP should undergo a thorough history and examination to investigate potential 
extraoral manifestations. The fact that 37 patients with OLP in this series were identified with simultaneous involve-
ment at more than one site highlights the need for exhaustive evaluation and multidisciplinary approaches to this 
disease.
Key words: Oral lichen planus, extra-oral manifestations, cutaneous lichen planus, genital lichen planus. 
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other areas of the body) and any related situations of 
emotional stress clearly recognized by the patient. 
The information collected was guaranteed by the con-
fidentiality that ensures the privacy and anonymity of 
the subjects regarding the confidential data involved in 
the research. From the information obtained through 
the medical records, a qualitative descriptive statisti-
cal analysis, frequency tables and cross - tables were 
carried out, in order to verify aspects relevant to the 
research. The program SPSS 14.0.1 for Windows was 
used to analyze the data collected. P ≤ 0.05 was consid-
ered to be statistically significant. 
Results
The total sample included 274 patients presenting lichen 
planus, 93 in subgroup A (enrolled from the University 
of Barcelona Dental Hospital) and 181 in subgroup B 
(enrolled from the Sacrat Cor Hospital, Barcelona). Of 
the whole sample, 141 presented OLP lesions, 40 as-
sociated with genital lesions and 131 with cutaneous 
lesions. Table 1 shows the distribution of cases by lo-
calization. In some patients, biopsies of the different 
areas presenting LP manifestations were performed to 
confirm diagnosis. 
The total sample included 208 women (75.91%) and 66 
Sacrat Cor Hospital Barcelona University 
Dental Hospital 
Total
Oral 22 (12.2%) 88 (37.3%) 110 (40.1%)
Oral-Genital 11 (6.1%) 01 (1.1%) 12 (4.4%)
Oral-Cutaneous 16 (8.8%) 02 (2.2%) 18 (6.6%)
Oral-Genital- Cutaneous 05 (2.8%) 02 (2.2%) 07 (2.6%
Genital 21 (11.6%) 00 (0.0%) 21 (7.7%)
Cutaneous 106 (58.6%) 00 (0.0%) 106 (38.7%)
Total 181 (100%) 93 (100%) 274 (100%)
Table 1: Distribution of lichen planus cases by site of origin: 147 (53.6%) presented some type of oral manifestation. 131 (47.8%) 
presented some type of cutaneous manifestation and 40 (14,6%) some type of genital manifestation.
men (24.08%), showing statistically significant differ-
ence (p≤0.005). Age ranged between 28 and 94 years, 
with a mean age of 56.40 years (SD± 14.34). Age and sex 
did not show significant differences between the two sub-
groups. Of the 93 patients in subgroup A, 80.6% (n=75) 
were women, with a mean age of 52.82 years (SD±13.02), 
while of the 181 patients in subgroup B, 72.9% (n=132) 
were women with a mean age of 53.61 years (SD±13,24). 
With regard to smoking, 201 patients were non-smokers 
(73.4%), and of these 40 were ex-smokers (19.9%). Seven-
ty-three patients smoked (26.6 %) (n=73), and 45 smoked 
over 20 cigarettes per day. Forty-four patients said that 
they drank alcohol (16.1%). No statistically significant 
differences in age and toxic habits were identified be-
tween the two subgroups. 
The systemic diseases most associated with the patient 
sample were psychological problems such as stress, anxi-
ety and depression (48%), hypertension (27%), gastric 
problems (12%) and diabetes (9.7%). This data was ho-
mogenous between the two subgroups. A family history 
of lichen planus was found in only two patients (0.72%) 
out of the total of 274, one presenting both oral and geni-
tal lesions, the other with cutaneous LP. 
i) Patients with oral lesions 
Of the total sample of 274 patients, 53.6% (n=147) pre-
sented oral lesions (Table 1). In patients with OLP, the 
clinical manifestation observed were: Wickham’s striae 
(68%), white plaques (52.3%) and erythema (36.73%). 
The main symptoms reported by OLP patients were pain 
(44.2%) and a stinging sensation (25.2%). Importantly, 
36 patients (24.5%) of the 147 with oral lesions did not 
report any symptoms. In 116 (78.9%) of these subjects, 
the most affected area was the buccal mucosa, followed 
by the tongue (43.5%) and the gums (34.6%) (Table 2).
As for intercrisis periods, a total of 53.7% of patients with 
OLP reported that they suffered with oral discomfort 
permanently, compared with patients who claimed they 
suffered discomfort at intervals of one to three months. 
Forty-four percent of patients with oral affectation, 
12.5% of patients with genital lesions and 22% with cu-
taneous affectation related the onset of the lesions with 
prior stressful situations or events. 
The most common treatment was topical corticoste-
roids (58.5%). An important finding was that monitor-
ing (without any treatment) was the only approach in 
39.5% of cases. The average duration of LP evolution, 
from the first moment of appearance, was 48 months 
ranging from a minimum of 3 months to a maximum 
of 15 years. Of the 147 patients with OLP, 2.7% (n=4) 
presented malignization at a previous site. 
ii) Patients with cutaneous lesions
Of 131 patients presenting cutaneous lesions, the most 
commonly affected areas were the body’s flexor surfac-
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Patients with oral lichen 
planus lesions
n=147






Ventral tongue 9 (6.12%)
Oral mucosa 116 (78.91%)
Lips 25 (17%)
Palate 3 (2.04%)






White plaque and erythema 4 (2.72%)
Erythema 83 (56.46%)
Table 2: Distribution of cases of OLP by demographic data, 
localization and clinical type.
es, representing 60.1% of cases. White patches associ-
ated with striae were observed in 45% of these cases. 
Violet papules (hyperpigmented patches) were present 
in 37.40% of subjects. Pruritus was the most commonly 
reported symptom (85.4%), followed by pain (25.9%). 
The mean evolution time of cutaneous lesions was 18 
months, ranging from a minimum of 1 month to a maxi-
mum of 13 years. These data showed little difference 
between patients presenting both cutaneous and oral 
LP, and patients presenting cutaneous LP alone. 
Of these 131 patients with cutaneous lichen planus, 19% 
(n=25) also presented oral lesions. Of patients present-
ing both cutaneous and oral lichen planus (n=25), 12% 
(n=3) presented cutaneous lesions prior to the appear-
ance of oral lesions (Table 3). The most common treat-
ment in all cases was topical corticosteroids (85.4%).
iii) Patients with genital lesions 
Of the total patient sample, 14.59% (40 patients) pre-
sented genital lesions, 23 women (57.5%) and 17 men 
(42.5%). The most affected area in women was the 
vulva (55%) and in men it was the glans (42.5%). Only 
one case presented anal manifestation. Erythema and 
erosive lesions were diagnosed in 55% of genital lichen 
planus. As for the most common symptoms, 80% re-
ported pruritus and 27.5% pain. Of the total number of 
patients with OLP, 4% (6 patients) also presented geni-
tal lesions, the genital manifestations appearing before 
Localization n (%)
Oral preceding cutaneous 08 (5.44%)
Oral preceding genital 06 (4.08%)
Genital preceding oral 03 (2.04%)
Cutaneous preceding oral 03 (2.04%)
Table 3: Total number and percentage of LP patients in relation to 
the appearance of affectation in more than one area, with one area 
preceding another.  
oral manifestations, while 2% of oral lesions appeared 
before genital lesions. Table 4 shows that concomitance 
between oral and genital lesions only occurred in two 
patients (1.36%).
Discussion
Lichen planus is a disease of the skin and mucosae; its 





Table 4: OLP cases with cutaneous and/or genital concomitance. 
The present work evaluated a patient series with lichen 
planus, investigating the pathology’s oral and extraoral 
manifestations.  
Lichen planus usually appears in subjects aged between 
50 and 70 years, the majority being women, regardless 
of whether the disease is oral or cutaneous (17,30). The 
present findings coincide with other research, as 75% of 
patients in the present study were women with a mean 
age of 56 years. The average duration of discomfort re-
ported by OLP patients was 1-3 months. Other studies 
report durations ranging between 3 and 12 months or 
even longer (up to 21 months) (31).
The results of previous studies indicate that the preva-
lence of smoking and alcohol consumption among OLP 
patients does not show statistically significant differ-
ence from the general population (32). Nevertheless, 
these habits should be registered in all clinical studies 
of patients with potentially malignant lesions. The pres-
ent study analyzed smoking and alcohol consumption, 
finding that 27% of the sample were smokers although 
no significant correlation between smoking and LP was 
identified. This finding is comparable to other previous 
works, such as Gimenez-García et al. (31), who found 
that 29% of subjects with LP were smokers. Another 
study also concluded that smoking did not predispose 
individuals to developing lichen planus (33). 
Although stress and depression are commonly thought 
Med Oral Patol Oral Cir Bucal. 2019 Jan 1;24 (1):e1-7.                                                                                                                                                          Cutaneous, genital and oral lichen planus
e5
to be factors for the appearance and evolution of LP, 
this cannot be confirmed categorically. According to 
the literature, the issue remains controversial, as it is 
difficult to determine whether or not psychic disorders 
are previous to the appearance of these painful chronic 
lesions or a consequence of the discomfort suffered. In 
the whole sample, the present study found that 48% of 
patients, 45% of whom were taking anxiolytics, report-
ed psychological problems such as stress, anxiety and 
depression, without significant difference between sub-
groups. However, one study that included psychometric 
assessment, found a higher level of anxiety among OLP 
patients than control patients (34). In another study (31), 
25% of patients clearly recognized a stressful situation 
previous to the appearance of cutaneous lesions and 8% 
suffered some depressive disorder.  
Several studies note the presence of emotional prob-
lems, stress, anxiety, and/or depression as responsible 
for triggering the disease, and also for triggering re-
lapses (30,34). The present results found that 41% of 
patients with oral lesions associated the outbreak with 
some stressful event, a value that dropped to 24% when 
the whole sample, including patients with cutaneous 
and genital affectation, was analyzed. 
In general, the most common cutaneous affectation 
(whether concomitant with oral lesions or not) appears 
on the arms, legs or flexor surfaces and presents pruri-
tus (29). In the present study, the distribution of lesions 
was similar to the distributions reported in the litera-
ture. Likewise, the severity of oral lesions did not seem 
to have any relation with the concomitance of cutane-
ous and/or genital lesions. For these patients presenting 
cutaneous manifestations, 60% occurred on the flexural 
surfaces of the body. 
Oral lichen planus (OLP) can adopt different clinical 
forms that may be singular or combined. Wickham’s 
striae are the main clinical sign of OLP and are funda-
mental to diagnosis. In addition to the reticular form, 
atrophic, erosive or plaque-like lesions are also ob-
served. In the 147 cases of OLP found in the present 
study, 68% presented striae, 52.3% showed white retic-
ular lichen and 36.73% erythema. The most commonly 
affected zone was the oral mucosa (78.9%), followed by 
the tongue (43,5%) and gums (34.6%). Munde et al. (35) 
analyzed 128 patients finding that the oral mucosa was 
the most frequent location (88.20%); the reticular type 
of OLP was the most common form (83.5%) followed by 
erosive (15.6%) and atrophic OLP (0.78%). 
As for the first appearance of lesions, the present study 
identified 6 patients who were aware of the presence of 
genital lesions but who also presented OLP of which 
they were unaware. Some 2% of patients presented OLP 
preceded by cutaneous and/or genital lesions. In this 
way, gynecologists or dermatologists may be the first to 
discover LP that is also present in the mouth, and should 
refer the patient to the appropriate quarter for diagnostic 
confirmation and treatment.   
In recent years, several articles have reported a con-
siderable increase in vulvovaginal affectation among 
women with OLP. These recommend systematic explo-
ration of the genitals for women with OLP even though 
they may present no symptoms (20,24). In a study by 
Eisen (26), 19% of 399 women with OLP were found 
to have genital lesions and 4.6% of 174 men. Coexist-
ing affectation of various mucosae is known as vulvo-
vaginal-gingival syndrome (36,37), which is character-
ized by erosions and desquamation of the vulva, vagina, 
and gingiva (26). The present study did not identify any 
cases of the syndrome, although 40 patients presented 
lichenoid lesions in genital areas, either concomitant 
with other areas or not. 
A family history of LP was found in only 2 patients 
(0,72%) out of the total of 274. Nevertheless, it is impor-
tant that medical notes show the presence of a family 
member with the same disease, as genetic predisposi-
tion is thought to be one element involved in OLP’s etio-
pathogenesis (38). 
For a long time, it has been suggested that patients with 
OLP show a greater incidence of diabetes than the gen-
eral population. OLP incidence in the diabetic popula-
tion is estimated to be 1.6% (39). Lopez-Jornet et al. 
(40) found type 2 diabetes in 11.5% of a sample of OLP 
patients. A study by Tovaru et al. (41) assessed 633 pa-
tients with OLP, of which 10% presented type 2 diabe-
tes. Another study (31) observed that 10% of the OLP 
patients assessed were diagnosed with diabetes mellitus 
and 30% reported a family history of diabetes. In the 
present patient sample, 9.7% were diabetic which con-
curs with the literature cited above. However, Munde et 
al. (35), found that only 2.4% of their sample presented 
diabetes mellitus. 
Twenty-seven per cent of patients in the present study 
were known to suffer hypertension, findings that exceed 
Lopez-Jornet et al. (40) and Munde et al. (35) who re-
port 19,2% and 11% hypertension among their samples. 
Several studies have demonstrated the premalignant 
potential of OLP although this remains a much-debat-
ed topic. In a cohort study by Bombeccari et al. (42), 
OLP was associated with a significant increase in the 
risk for oral squamous cell carcinoma (OSCC). The 
erosive and atrophic forms of OLP were more prevalent 
among patients whose lesions developed OSCC. This 
outcome is consistent with other reports of association 
between OLP and OSCC (43-46). But an earlier study 
of OLP patients in Northwestern Italy failed to identify 
any evidence that non-reticular OLP lesions are more 
predisposed to malignant transformation (13). In the 
present study, 4 patients (2.7%) presented maligniza-
tion, of whom 2 were smokers and the other 2 smok-
ers and drinkers. Kaplan et al. (46), in a study of 171 
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patients, demonstrated that the prevalence of carcinoma 
was 5.8% and that malignant transformation can occur 
in any of OLP’s clinical forms. The process of malig-
nant transformation is still unclear (10,12,16). A recall 
system for OLP patients might be useful to facilitate the 
early diagnosis of oral cancer with the aim of reducing 
morbidity and mortality (9). In the present sample, the 
option to screen cases regularly for the sake of early de-
tection had been taken up in 39.5% of cases.
In most cases (58.5%), the main type of treatment reg-
istered in the present study, whether oral, cutaneous, or 
genital LP, was the use of topical corticosteroids, a find-
ing that concurs with the literature (35,42). Systemic 
corticosteroids are the first-line treatment for severe, 
widespread OLP and for LP involving other mucocuta-
neous sites resistant to topical therapies.
In many cases, the first and/or only manifestation of LP 
is found in the oral cavity and so it is up to the dentist to 
identify and manage the disease. Any patient with OLP 
should undergo a thorough examination to discover any 
other extraoral manifestations. The fact that 37 patients 
with OLP in this series were identified with simulta-
neous involvement in more than one site highlights the 
importance of exhaustive evaluation and the need for a 
multidisciplinary approach to this disease.
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